Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.

Author: ChillemiGiovanni, ColettaAndrea, D'AnnessaIlda, DesideriAlessandro, ManciniGiordano, SannaNico

Paper Details 
Original Abstract of the Article :
Human topoisomerase I catalyzes the relaxation of DNA supercoils in fundamental cell processes like transcription, replication and chromosomal segregation. It is the only target of the camptothecin family of anticancer drugs. Among these, topotecan has been used to treat lung and ovarian carcinoma f...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880615/

データ提供:米国国立医学図書館(NLM)

Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex

This research delves into the molecular mechanisms by which topotecan, an anticancer drug belonging to the camptothecin family, exerts its therapeutic effect. The study focuses on the interaction of topotecan with human topoisomerase I, an enzyme crucial for DNA replication, transcription, and chromosomal segregation. The researchers explore the structural and dynamical effects of topotecan on the topoisomerase I-DNA complex, providing insights into its mode of action. The study highlights the critical role of topoisomerase I in fundamental cellular processes, making it a prime target for anticancer drugs. Camptothecins, including topotecan, bind to the covalent intermediate formed between the enzyme and DNA, effectively trapping the complex and inhibiting the religation process. This disruption leads to the formation of lethal double-strand DNA breaks, ultimately triggering cell death.

Topotecan: a targeted approach to combat cancer

This research sheds light on the molecular mechanism by which topotecan, an anticancer drug, interacts with human topoisomerase I, leading to DNA damage and cell death. The study emphasizes the importance of understanding the molecular interactions between drugs and their targets to develop effective therapies.

Health implications and everyday applications

The research provides a deeper understanding of the molecular mechanisms underlying the anticancer activity of topotecan. This knowledge is crucial for developing new and more effective cancer therapies that target specific cellular processes.

Dr.Camel's Conclusion

Like a camel navigating the intricate pathways of the desert, researchers are unraveling the complex interactions between drugs and their targets. This study provides valuable insights into the molecular mechanisms of topotecan, a powerful tool in the fight against cancer.

Date :
  1. Date Completed 2010-09-01
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20532182

DOI: Digital Object Identifier

PMC2880615

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.